PronoKal Health Group SL
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PronoKal Health Group SL - overview
Established
2004
Location
Barcelona, -, Spain
Primary Industry
Food
About
PronoKal Health Group SL provides specialized weight loss solutions through its comprehensive Método PnK program, focusing on personalized dietary plans, nutritional coaching, and fitness guidance for sustainable health management. Founded in 2004 in Barcelona, Spain, PronoKal Health Group SL specializes in medically supervised weight loss solutions. The company has undergone significant growth, culminating in a TRADE SALE valued at EUR 100. 00 mn to Nestle Health Science SA in February 2022.
This acquisition is expected to enhance PronoKal's market presence in Southern Europe. The company has successfully raised a total of EUR 100. 00 mn across two funding rounds. PronoKal specializes in weight loss solutions through its Método PnK program, offering personalized dietary plans, nutritional coaching, and fitness guidance tailored to individual needs.
Key products include dietary supplements and meal replacements designed to support weight management. The program involves healthcare professionals, such as doctors and nutrition coaches, providing ongoing support to clients facing obesity and weight management challenges across Europe and Latin America. In 2020, PronoKal reported a revenue of EUR 22,225,693. 90 with an EBITDA of EUR 887,483.
50. Revenue is generated through direct-to-consumer sales of weight loss programs, dietary supplements, and meal plans, structured around initial consultation fees and subscription payments for ongoing support. Following the acquisition by Nestle Health Science SA in February 2022, PronoKal plans to leverage its expanded resources to design and launch new products aimed at enhancing its weight management offerings. The company is focusing on expanding its reach in Southern Europe, with strategic initiatives set to roll out by the end of 2022.
The acquisition funding will underpin these expansion efforts and support the development of innovative health solutions.
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements, Healthcare
Website
www.pronokal.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
PronoKal Health Group SL - timeline of key events
PronoKal Health Group SL - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 19,151,389.4 | 19,815,860.9 | 22,291,212 | 19,346,291 | 21,836,919 | 19,461,956 | - | - | - | - |
| % Revenue Growth (YoY) | - | 3.5% | 12.5% | (13.2%) | 12.9% | (10.9%) | - | - | - | - |
| EBITDA (USD) | 81,468.3 | (1,085,983.6) | 447,788 | 913,199 | 803,729 | 777,126 | - | - | - | - |
| Operating Income (USD) | 81,468.3 | (1,085,983.6) | 447,788 | 913,199 | 785,810 | 756,864 | - | - | - | - |
| Operating Margin | 0.4% | (5.5%) | 2.0% | 4.7% | 3.6% | 3.9% | - | - | - | - |
| % EBITDA Margin | 0.4% | (5.5%) | 2.0% | 4.7% | 3.7% | 4.0% | - | - | - | - |
| NET Income (USD) | 58,296.9 | (815,579.6) | 296,493 | 745,349 | 597,171 | 526,910 | - | - | - | - |
| % Net Margin | 0.3% | (4.1%) | 1.3% | 3.9% | 2.7% | 2.7% | - | - | - | - |
PronoKal Health Group SL - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | PronoKal Health Group SL | - | ||||||||
| Buyout | Completed | PronoKal Health Group SL | - |
Displaying 1 - 2 of 2
PronoKal Health Group SL - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.